$MDVN has the UCLA lab cold on ARN509. Astellas, however, has the right of refusal on the compound as part of their existing deal with Medivation.
Unless otherwise indicated, this is the personal viewpoint of David Miller and not necessarily that of Biotech Stock Research, LLC. We're on Twitter at BiotechStockRsr